Wiregrass Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$644K Sell
26,759
-278
-1% -$7.27K 0.44% 65
2026
Q1
$759K Buy
27,037
+1,546
+6% +$41.2K 0.63% 53
2025
Q4
$635K Buy
+25,491
New +$643K 0.53% 57

Other funds holding PFE

Wiregrass Investment Management's PFE Position: Q2 2026 in Review

Wiregrass Investment Management reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $7.27K and leaving 26,759 shares worth $644K. The position accounts for 0.44% of the portfolio, ranked #65.

Wiregrass Investment Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $759K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wiregrass Investment Management held 26,759 shares of Pfizer worth $644K as of Q2 2026.
  • Wiregrass Investment Management sold 278 Pfizer shares in Q2 2026, an estimated $7.27K.
  • Pfizer made up 0.44% of Wiregrass Investment Management's portfolio in Q2 2026, its #65 holding.
  • Wiregrass Investment Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Wiregrass Investment Management's Pfizer position peaked at $759K in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wiregrass Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.